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Obesity is a chronic disease with associated 
increases in the incidence, and a reduction in survival, 
of many cancer types. Obesity results from an imbal-
ance in calorie intake and calorie requirement. This 
study aimed to investigate the separate effects of high-
fat diet and obesity on cancer in an animal model resis-
tant to diet-induced obesity. Male BALB/c mice fed 
long-term on a high-fat, Western-style diet were im-
planted with syngeneic CT26 colon adenocarcinoma 
cells and compared to mice fed normal diet. BALB/c 
mice on high-fat diet were 10% heavier than mice fed 
normal diet, with no difference in tumour growth rates 
or tumour cell proliferation. Subgroups of mice that 
became obese on high-fat diet, however, showed in-
creased tumour growth rates compared to mice fed 
normal diet, whereas mice that remained slim showed 
no difference in tumour growth. Protein arrays identi-
fied several adipokines that were expressed at different 
levels in the subgroups, including serum Tissue Inhibi-
tors of Metallo-Proteinases (TIMP-1) and tumour C-
Reactive Protein (CRP). In conclusion, tumour growth 
was enhanced in mice unable to resist obesity, and adi-
pokine profiles were affected by the animals’ ability to 
resist obesity.  
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Tumour growth in mice resistant to diet-induced obesity 
Introduction 
 
There is convincing epidemiological evidence that 
body fatness is a strong risk factor for a range of can-
cers, including colorectal, breast, pancreatic, endo-
metrial and ovarian, with over 20% of obesity-
associated cancers in the US attributable to excess adi-
posity per se (World Cancer Research Fund 2007). 
Increased adiposity is not only associated with in-
creased cancer incidence, but also with increased mor-
tality and reduced survival following cancer diagnosis 
(Parekh et al. 2012). Specifically, for patients with co-
lorectal cancer, pre-diagnostic body mass index (BMI) 
is predictive of response to therapy and survival 
(Campbell et al. 2012, Meyerhardt et al. 2004). The 
mechanisms underlying this association are under in-
tense investigation, but have not been resolved. 
Chronic inflammation is a plausible link between obe-
sity and cancer, but other factors will also be contribut-
ing (Park et al. 2014).  
 Obesity results from an imbalance in calorie 
intake and calorie requirement, and is modulated by 
genetic predisposition. For this study, obesity-resistant 
BALB/c mice (Fearnside et al. 2008, Montgomery et 
al. 2013, Nishikawa et al. 2012, Waller-Evans et al. 
2013) fed a Western-style, high-fat diet were chosen. 
These wild type mice are immune-competent, which is 
essential to study the inflammatory effects of obesity, 
and thus require syngeneic mouse tumours, such as the 
CT26 colon adenocarcinoma (Meijer et al. 2008). This 
study aimed to investigate the associations between 
diet, obesity and cancer risk, and specifically, the sepa-
rate effects of high fat diet and obesity in an animal 
model with cancer. 
 
Materials and Methods 
 
Ethics 
Approval for this study was obtained from the Univer-
sity of Otago Animal Ethics Committee (ethics ap-
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proval number C6/10). International guidelines on ani-
mal welfare were strictly followed (Workman et al. 
2010). 
 
Mouse model 
BALB/c mice were bred in-house, and male mice were 
chosen after weaning. Mice were weighed at least once 
a week. Due to fighting, male mice were all housed 
singly for the last 4 months of the study. Mice fed on 
high fat diet were divided into subgroups according to 
their final body weight; HFF >35g, HFM 32-35g, HFS 
<32g. 
 
Diet 
Male mice (4 weeks old), following weaning, were 
randomly divided into two groups, with one of the 
groups allowed to feed ad libitum on a defined high fat 
diet (HF, ‘Western fast food’ diet from Speciality 
Feeds, Australia) and the other on normal diet (ND, 
Speciality Feeds, Australia) until six months of age. 
The HF diet contained 40% of total digestible energy 
derived from lipids, with 21% total fat, 4.7% crude 
fibre, 1000 IU/kg vitamin D3 and 0.6% calcium, 
whereas ND had 8.9% energy derived from lipids, 
with 4.8% total fat, 4.8% crude fibre, 2000 IU/kg vita-
min D3 and 0.8% calcium. 
 
Tumour model 
BALB/c mice at age 6 months were implanted subcu-
taneously (s.c.) in one flank with 1x106 CT26 tumour 
cells (undifferentiated, syngeneic colon adenocarci-
noma from the American Type Culture Collection, 
Cryosite Distribution, Australia). Tumour volume was 
measured daily with callipers, and individual animals 
were sacrificed when tumours reached a maximum 
volume of 1000 mm3 (V = π/6 x width2 x length). The 
animals were sacrificed by isoflurane (Baxter, Deer-
field, IL, USA) overdose and cervical dislocation, and 
the tumours excised, organs harvested and blood col-
lected. Organs and tumours were weighed, and divided 
in half, with one half immediately flash frozen, and the 
remainder fixed using formalin. Serum, organs and 
tumours were stored frozen at -80oC. 
 
Immunohistochemistry 
Formalin-fixed tumours were prepared for paraffin 
embedded (FFPE) blocks, sectioned at 3-5 μm and 
stained with Haematoxylin and Eosin (H&E) to show 
tissue morphology. Staining of phosphohistone H3 
(pHH3) was used to determine tumour cell prolifera-
tion rates (Gerring et al. 2015). Immunostaining was 
carried out following standard protocols for heat acti-
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Figure 1. Comparison of mouse weights (A), food con-
sumption (B) and organ weights (C) in mice fed on high fat 
diet (HF) vs normal diet (ND). (A) Young male BALB/c 
mice on HF or ND diet were weighed weekly for 5 months, 
prior to tumour implantation and sacrifice (HF n=31, ND 
n=10). (B) Daily food consumption over two weeks was 
analysed in groups of 5 mice each HF and ND. (C) Organs 
and tumour were weighed (HF n=20, ND n=9). Data were 
analysed using 2-way ANOVA followed by post-hoc Bon-
ferroni tests; ** p<0.01, *** p<0.001.  
vated antigen retrieval in citrate buffer to detect pHH3 
(1:5000, Abcam, Melbourne, Australia) and using the 
Anti-mouse HRP-DAB Cell and Tissue staining kit 
(R&D Systems, Pharmaco, Auckland, NZ). Scoring of 
pHH3 was carried out on viable tumour tissue by 
counting positive cells in 12 random views at high 
magnification (x40 objective) for each section, relative 
to total number of cells per view. 
 
Adipokine array 
Serum and tumour lysates were used to identify 
changes in the adipokine profiles. Frozen tumour tis-
sues were homogenised to a fine powder in liquid ni-
trogen using a chilled mortar and pestle. The tissue wet 
weight was measured and phosphate buffered saline 
with protease inhibitors (Sigma Aldrich, Auckland, 
New Zealand) was added to make a homogeneous sus-
pension. Serum or lysates were pooled from n=4 mice 
per group (ND and 3 HF groups: HFF, HFM, HFS), 
and a ProteomeProfiler Mouse Adipokine Array (R&D 
Systems, Pharmaco, Auckland, NZ) was used to deter-
mine relative levels of selected adipokines according 
to manufacturer’s instruction. The array allows the 
simultaneous detection of 38 different obesity-related 
molecules. Briefly, 40 μg of protein (tumour lysate) or 
100 μl serum (1/100 dilution) were mixed with a cock-
tail of biotinylated antibodies, and identified with 
Streptavidin-HRP and chemi-luminescent detection. 
Relative protein levels were determined using pixel 
density (using Alliance 2.7 and UVI Band V12.14 
software, Uvitec, Cambridge, UK) standardised to ref-
erence spots on the array. 
 
Enzyme linked immune-sorbent assay (ELISA) 
Insulin-like growth factor binding protein 5 (IGFBP-5) 
in serum and tumour lysates was quantified using an 
IGFBP-5 mouse ELISA kit (Abcam, Sapphire Biosci-
ence, Redfern, Australia) according to manufacturer’s 
instructions. Tumour lysate was used at 40 μg/100 ml 
and serum was diluted 1/100. 
Journal of Molecular Biochemistry, 2015   44 
Figure 2. Tumour growth (A) and tumour cell proliferation (B, C) in mice fed western style, high fat diet (HF) or normal diet 
(ND). (A) BALB/c mice fed on HF or ND were implanted s.c. with CT26 tumour cells, and tumour growth was recorded as 
time taken to reach 200mm3 and time to reach 4x tumour volume (200-800mm3) (HF n=10, ND n=5). (B) Tumour sections were 
stained for the proliferation marker pHH3 and positive cells were counted in 12 random views, expressed as percentage of total 
tumour cells. (C) An example of pHH3 staining (brown) in tumour sections of mice fed HF or ND is shown; size bar indicated 
50 μm. Data were analysed using 2-way ANOVA, ns = not significant. 
Statistical analysis 
Statistics and graphical analysis were done using 
GraphPad Prism version 5.08. HF vs ND were com-
pared using one and two way ANOVA, with post-hoc 
Bonferroni or post-hoc Tukey tests, as appropriate, 
with significance assumed as p<0.05. 
 
Results 
 
Male BALB/c mice are resistant to diet-induced 
obesity 
After six months feeding on Western style, high fat 
(HF) diet, male BALB/c mice weighed significantly 
more (range 27 – 39g, p=0.003) than mice on standard 
normal diet (ND, range 27g – 34g), but this difference 
accounted for only about 10% of their weight (mean 
33g vs 30g on day 158 for HF vs ND, respectively) 
(Figure 1A). This small difference can partly be ac-
counted for by the observation that the mice preferred 
normal mouse chow to HF, as mice on HF consumed 
significantly less food (p<0.001, Figure 1B). Organ 
weights were similar in the two feeding groups, with 
the exception of omental fat, which weighed 2.7-times 
more in HF mice compared to ND mice (p<0.001, Fig-
ure 1C). As expected, tumour weights did not differ as 
they were removed when they reached a certain size 
(1000 mm3), and not after a specified number of days 
post implantation. 
 
Tumour growth rates and cell proliferation do not 
differ according to diet  
Tumour growth rates, defined as lag phase (time from 
implantation to reach 200 mm3) and log phase (time to 
reach 4x volume, i.e. growth from 200-800 mm3) did 
not differ between the two feeding groups (p>0.05, 
Figure 2A). This was confirmed by staining for the 
pHH3 proliferation marker (Figure 2B and C), which 
showed no significant difference between tumours 
grown in mice on HF vs ND (p>0.05). 
 
Resistance to diet-induced obesity affects tumour 
growth 
Mice fed HF diet showed considerable variation in 
their final body weight as well as omental fat weight, 
and could be separated into three groups; those that 
became obese on HF diet (HFF), those that remained 
slim (HFS) and an intermediate group (HFM) (Figure 
3A and B). When tumour growth was analysed accord-
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Figure 3. Subgroup analysis of mice more or less resistant to diet-induced obesity. BALB/c mice fed on HF diet were divided 
into those that became obese (HFF, n=4), those that stayed slim (HFS, n=4) and those in-between (HFM, n=4), and compared to 
mice on normal diet (ND, n=4). (A) Final mouse weight and (B) fat weights were significantly different in the subgroups. (C) 
Tumour growth was recorded as time taken to reach 200mm3 and time to reach 4x tumour volume (200-800mm3) (n=3-6). Data 
were analysed using 2-way ANOVA followed by post-hoc Bonferroni tests; * p<0.05, ** p<0.01, *** p<0.001. 
ing to the mice’s propensity to become obese, tumours 
in the HFF group grew significantly faster (200-
800mm3) than those in the ND group (p<0.05), and 
faster than the other two HF groups, although that was 
not significant (p>0.05) (Figure 3C). Staining for 
pHH3 showed that tumours in the HFS group had a 
lower proliferation rate than the other groups, but this 
did not reach significance (p>0.05, results not shown). 
 
Resistance to diet-induced obesity affects adipokine 
profile 
A range of 38 adipokines in the serum and tumour lys-
ates of these groups of mice were analysed by proteo-
mic profiling (Figure 4A and B, Supplementary table 
1). In serum, of the 21 detected adipokines, 9 increased 
by more than 50% and none decreased by more than 
50%, compared to serum from mice on ND (Figure 
4A). A more than 2-fold increase was observed for 
adiponectin (HFM and HFS), fetuin A (HFM), IGFBP-
1 (HFS), pentraxin 2 (HFM) and TIMP-1 (HFF), com-
pared to ND in serum. Within the three high fat diet 
groups, all serum adipokines were increased in the two 
non-obese groups, compared to the obese group (with 
the exception of TIMP-1). In tumour lysates, of the 20 
adipokines detected, 5 increased by more than 50% 
and none decreased by more than 50%, compared to 
lysates from mice on ND (Figure 4B). A more than 2-
fold increase was observed for CRP (HFF) and IGFBP
-5 (HFF) compared to ND in tumour. 
 IGFBP-5 was analysed further using ELISA 
(Figure 4C and D), as it showed differential levels in 
both serum and tumours. IGFBP-5 levels in serum 
were increased in HFF mice, whereas in tumour lys-
ates the HFS group showed highest levels, compared 
to the ND group, but none were statistically significant 
(p>0.05, Figure 4C and D).  
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Figure 4. Protein array analysis and IGFBP-5 ELISA data of mice fed on Western style, high fat diet (HF) compared to normal 
diet (ND). BALB/c mice fed on HF diet were divided into those that became obese (HFF, n=4), those that stayed slim (HFS, 
n=4) and those in-between (HFM, n=4), and compared to mice on normal diet (ND, n=4). (A) Serum and (B) tumour lysates 
were analysed using an adipokine array, and IGFBP-5 concentrations were measured in (C) serum and (D) tumour lysates by 
ELISA. Data were analysed using 2-way ANOVA, ns = not significant. 
Discussion 
 
This study confirmed that BALB/c mice are resistant 
to diet-induced obesity, but within this group of mice, 
some animals remained slim while others became 
obese. This inherent variance affected tumour growth 
such that obese mice on high fat diet showed increased 
tumour growth rates compared to mice on normal diet, 
whereas non-obese mice on high fat diet showed no 
difference in tumour growth rates. The implications of 
these findings is that high fat diet alone does not drive 
tumour growth, but rather inherent factors within the 
host.  
 Mouse models have been widely used to in-
vestigate the effect of diet-induced obesity on cancer 
risk and progression. Among several strains of labora-
tory mice, BALB/c mice were identified as one of the 
most resistant ones to diet-induced obesity (Fearnside 
et al. 2008, Montgomery et al. 2013, Nishikawa et al. 
2012, Waller-Evans et al. 2013) although one study 
reported higher fat gain and hepatic lipid accumulation 
in BALB/c compared to others (Nishikawa et al. 
2007). C57BL/6 mice are highly susceptible to diet-
induced obesity and hence the majority of studies have 
been carried out in these animals. These C57BL/6 
studies demonstrated that dietary factors contribute 
substantially to the risk of colorectal (Dougherty et al. 
2009, Newmark et al. 2001, Richter et al. 1995, Riso 
et al. 1996) and other cancers (Xue et al. 1996). Yet 
tumour growth in our study relied primarily on the pro-
pensity of mice to become obese and not their diet per 
se. 
 This study did not show any effect of Western 
style, high fat diet per se on tumour growth. This is in 
contrast to two studies done by Park et al., who dem-
onstrated an increase in CT26 colorectal (Park et al. 
2012) and 4T1 breast tumour (Kim et al. 2011) growth 
and metastases in BALB/c mice fed high fat diet. In a 
direct comparison between the study by Park et al 
(2012) and this study, the main differences were length 
of feeding (16 weeks vs 20 weeks), the method of tu-
mour implantation (CT26 tumours were implanted in 
Matrigel vs PBS), and composition of the diet (60 
kcal% fat vs 40% energy derived from fat, identical 
quantities of vitamins and minerals vs reduced vitamin 
D and calcium). Low calcium and reduced vitamin D 
were previously identified as important risk factors in 
the Western style diet in addition to high fat content 
(Erdelyi et al. 2009, Richter et al. 1995). Thus, these 
alterations may explain the differences in outcome be-
tween the studies, but also emphasise that enhance-
ment of tumour growth by high fat diet may not be a 
universal fact, and that host factors are likely to play 
an important role. 
 In BALB/c mice, Western style diet has been 
shown to induce DNA binding activity of nuclear fac-
tor k-B and increase serum concentrations of tumour 
necrosis factor alpha (Kim et al. 2010), to change lev-
els of choline-containing phospholipids (Kim et al. 
2014), and to deregulate genes involved in fatty acid 
biosynthesis and uptake (Nishikawa et al. 2012), as 
well as to deregulate signalling pathways of the protea-
some, PPAR signalling and ubiquitin-mediated prote-
olysis (Waller-Evans et al. 2013). Our data indicated 
that several adipokines changed with diet, with the ma-
jority showing increased levels in obesity-resistant 
mice compared to obese BALB/c mice. Exceptions 
were increased Tissue Inhibitors of Metallo-
Proteinases (TIMP-1) levels in serum and increased C-
Reactive Protein (CRP) levels in tumour lysates of 
HFF mice. TIMPs play a vital role in the development 
of obesity by supporting adipogenesis and extracellular 
matrix degradation (Crandall et al. 1997). In vivo stud-
ies have shown that elevated circulating levels of 
TIMP-1 derived from the primary tumour prepare the 
metastatic niche by upregulating factors in the liver 
that induce homing of tumour cells and promote for-
mation of diffuse micrometastases in the liver tissue 
(Kopitz et al. 2007, Schelter et al. 2011). Our study 
observed no macroscopic metastases in the liver, but 
could not rule out single cell tumour dispersions. CRP 
is an acute-phase protein involved in inflammation and 
is associated with obesity (Nanri et al. 2007). Both 
TIMP-1 and CRP are likely to be of importance in tu-
mour growth in obesity-resistant mice but further work 
is required to confirm our observations. The effect of 
diet and obesity on the IGF-1 axis in this study, spe-
cifically IGFBP-5, were subtle and similarly require 
further work. It is interesting that, although adi-
ponectin was reduced in the HFF group of mice com-
pared to HFS/M mice, as expected (Lamas et al. 
2015), HFF mice had levels similar to the ND group. 
 In conclusion, tumour growth was enhanced in 
animals unable to resist obesity and this affected serum 
and tumour adipokine profiles. The implications of our 
data are that diet per se may not be the main driving 
factor in diet-induced obesity, but rather the host re-
sponse to this challenge. 
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